Cullinan Therapeutics Inc
Weekly Stock Prices Chart
This stock price chart for Cullinan Therapeutics Inc, symbol CGEM, Nasdaq Stock Exchange is updated
weekly. TradingCharts.com offers over 30 thousand free stock price charts and stock market quotes.
[Add symbol to "MyMenu"]
Daily and Monthly charts are also available for Cullinan Therapeutics Inc.
Most Recent HeadlinesMNA: Jun 1st, 2024, 19:01Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
MNA: Jun 1st, 2024, 18:18Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
MNA: Jun 1st, 2024, 17:28Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
MNA: Jun 1st, 2024, 16:34Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
MNA: Jun 1st, 2024, 15:41Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
MNA: Jun 1st, 2024, 14:56Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
MNA: Jun 1st, 2024, 14:11Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
MNA: Jun 1st, 2024, 13:17Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
MNA: Jun 1st, 2024, 12:23Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
MNA: Jun 1st, 2024, 11:25Length: 11188 Cullinan Therapeutics Announces Positive Initial Data From Pivotal Phase 2B REZILIENT1 Study Of Zipalertinib
|